Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Guangdong Hybribio Biotech Company

2003 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
300639 STOCK SYMBOL
$2.48 SHARE PRICE (As of Wednesday Closing)
Description

Manufacturer of in-vitro diagnostic related products. The company develops molecular diagnostic reagents and equipment like in-vitro diagnostic kits used for human papilloma virus, sexually transmitted diseases, thalassemia gene diagnostic kit, ,parental neonatal, female sample collection kit, and deoxyribonucleic acid (DNA) extraction kit.

Website
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
SHE
Primary Office
  • 27/F, Bonham Trade Centre
  • 50 Bonham Strand, Sheung Wan
  • Hong Kong
  • China

+86 00000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Guangdong Hybribio Biotech Company’s full profile, request a free trial.

Guangdong Hybribio Biotech Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.48 - $6.10 $480M $2.54 $0.08 2.49M 182M

Guangdong Hybribio Biotech Company Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2013
31-Dec-2013
Enterprise Value 798,342 1,104,635
Revenue 75,338 70,892 59,798 29,711
EBITDA 16,747 20,154 16,393 5,386
Net Income 14,445 13,793 11,424 4,743
Total Assets 183,011 163,837 83,406 44,721
Total Debt 0 1,440 6,553
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangdong Hybribio Biotech Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Guangdong Hybribio Biotech Company‘s full profile, request access.

Request full access to PitchBook